Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Deficit

v3.21.1
Consolidated Statements of Changes in Shareholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Oct. 28, 2019
Balance, shares at Oct. 28, 2019      
Issuance of common stock to founders $ 50 (50)
Issuance of common stock to founders, shares 500,000      
Expenses paid on behalf of company - related party 640 640
Net loss     (1,550) (1,550)
Balance at Dec. 31, 2019 $ 50 590 (1,550) (910)
Balance, shares at Dec. 31, 2019 500,000      
Common stock issued in conjunction with reverse merger $ 3,368 606,813 610,181
Common stock issued in conjunction with reverse merger, shares 33,686,169      
Warrants issued to third parties in conjunction with debt issuance 223,560 223,560
Beneficial conversion feature in conjunction with debt issuance 129,938 129,938
Common stock issued to third parties in conjunction with exchange of debt $ 102 395,898 396,000
Common stock issued to third parties in conjunction with exchange of debt, shares 1,015,344      
Net loss (1,259,590) (1,259,590)
Balance at Dec. 31, 2020 $ 3,520 $ 1,356,799 $ (1,261,140) $ 99,179
Balance, shares at Dec. 31, 2020 35,201,513